Cargando…

Malignant Mixed Mullerian Tumor: An Immunohistochemical Study

Malignant mixed Mullerian tumor (MMMT) is an uncommon aggressive neoplasm composed of both malignant epithelial and mesenchymal components. In this study, immunohistochemical stains of germ cell markers, including SALL4, OCT3/4, glypican-3, and alpha-fetal protein (AFP), and CDX2 were performed in a...

Descripción completa

Detalles Bibliográficos
Autores principales: Bing, Zhanyong, Pasha, Theresa, Wang, Li-Ping, Zhang, Paul J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3400397/
https://www.ncbi.nlm.nih.gov/pubmed/22848863
http://dx.doi.org/10.1155/2012/569609
_version_ 1782238486276866048
author Bing, Zhanyong
Pasha, Theresa
Wang, Li-Ping
Zhang, Paul J.
author_facet Bing, Zhanyong
Pasha, Theresa
Wang, Li-Ping
Zhang, Paul J.
author_sort Bing, Zhanyong
collection PubMed
description Malignant mixed Mullerian tumor (MMMT) is an uncommon aggressive neoplasm composed of both malignant epithelial and mesenchymal components. In this study, immunohistochemical stains of germ cell markers, including SALL4, OCT3/4, glypican-3, and alpha-fetal protein (AFP), and CDX2 were performed in a series of MMMTs. SALL4 nuclear immunoreactivity was detected in 6 out of 19 cases (33%). The staining extent ranged from focal to extensive. The staining intensity was usually intermediate to strong (the score ranged from 1.5 to 3, and average score was 2.3 ± 0.5 in the positive cases). In addition, glypican-3 cytoplasmic reactivity was detected in 14 out of 16 cases (88%) with a mean score of 1.8 ± 0.7 (score ranging from 1 to 3). In contrast, OCT3/4 was only positive in 1 out of 19 cases and AFP in 2 out of 18 cases (11%). In summary, SALL4 and glypican-3 were frequently expressed in a subset of MMMTs. Their roles in the pathogenesis and biology of MMMT are yet to be determined. MMMT should be included in the differential diagnosis when a tumor is positive for SALL4 and/or glypican-3.
format Online
Article
Text
id pubmed-3400397
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-34003972012-07-30 Malignant Mixed Mullerian Tumor: An Immunohistochemical Study Bing, Zhanyong Pasha, Theresa Wang, Li-Ping Zhang, Paul J. Patholog Res Int Research Article Malignant mixed Mullerian tumor (MMMT) is an uncommon aggressive neoplasm composed of both malignant epithelial and mesenchymal components. In this study, immunohistochemical stains of germ cell markers, including SALL4, OCT3/4, glypican-3, and alpha-fetal protein (AFP), and CDX2 were performed in a series of MMMTs. SALL4 nuclear immunoreactivity was detected in 6 out of 19 cases (33%). The staining extent ranged from focal to extensive. The staining intensity was usually intermediate to strong (the score ranged from 1.5 to 3, and average score was 2.3 ± 0.5 in the positive cases). In addition, glypican-3 cytoplasmic reactivity was detected in 14 out of 16 cases (88%) with a mean score of 1.8 ± 0.7 (score ranging from 1 to 3). In contrast, OCT3/4 was only positive in 1 out of 19 cases and AFP in 2 out of 18 cases (11%). In summary, SALL4 and glypican-3 were frequently expressed in a subset of MMMTs. Their roles in the pathogenesis and biology of MMMT are yet to be determined. MMMT should be included in the differential diagnosis when a tumor is positive for SALL4 and/or glypican-3. Hindawi Publishing Corporation 2012 2012-07-10 /pmc/articles/PMC3400397/ /pubmed/22848863 http://dx.doi.org/10.1155/2012/569609 Text en Copyright © 2012 Zhanyong Bing et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Bing, Zhanyong
Pasha, Theresa
Wang, Li-Ping
Zhang, Paul J.
Malignant Mixed Mullerian Tumor: An Immunohistochemical Study
title Malignant Mixed Mullerian Tumor: An Immunohistochemical Study
title_full Malignant Mixed Mullerian Tumor: An Immunohistochemical Study
title_fullStr Malignant Mixed Mullerian Tumor: An Immunohistochemical Study
title_full_unstemmed Malignant Mixed Mullerian Tumor: An Immunohistochemical Study
title_short Malignant Mixed Mullerian Tumor: An Immunohistochemical Study
title_sort malignant mixed mullerian tumor: an immunohistochemical study
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3400397/
https://www.ncbi.nlm.nih.gov/pubmed/22848863
http://dx.doi.org/10.1155/2012/569609
work_keys_str_mv AT bingzhanyong malignantmixedmulleriantumoranimmunohistochemicalstudy
AT pashatheresa malignantmixedmulleriantumoranimmunohistochemicalstudy
AT wangliping malignantmixedmulleriantumoranimmunohistochemicalstudy
AT zhangpaulj malignantmixedmulleriantumoranimmunohistochemicalstudy